{"id":"https://openalex.org/W2094250264","doi":"https://doi.org/10.2337/dc12-0709","title":"The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes","display_name":"The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes","alternate_titles":[],"publication_year":2013,"publication_date":"2013-02-13","ids":{"openalex":"https://openalex.org/W2094250264","doi":"https://doi.org/10.2337/dc12-0709","mag":"2094250264","pmid":"https://pubmed.ncbi.nlm.nih.gov/23139373","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3579343"},"language":"en","primary_location":{"id":"doi:10.2337/dc12-0709","doi":"https://doi.org/10.2337/dc12-0709","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-0709","pdf_url":"https://care.diabetesjournals.org/content/diacare/36/3/498.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2094250264"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://care.diabetesjournals.org/content/diacare/36/3/498.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Julio Rosenstock","raw_affiliation_strings":["Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas","Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas","institution_ids":["https://openalex.org/I2800474951"]},{"raw_affiliation_string":"Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA","institution_ids":["https://openalex.org/I2800474951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028793097","display_name":"Bogdan Balas","orcid":"https://orcid.org/0000-0002-2384-9096","observed_orcids":["https://orcid.org/0000-0002-2384-9096"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bogdan Balas","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025169113","display_name":"Bernard H. Charbonnel","orcid":"https://orcid.org/0000-0002-2117-9279","observed_orcids":["https://orcid.org/0000-0002-2117-9279"]},"institutions":[{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard Charbonnel","raw_affiliation_strings":["Department of Internal Medicine, Endocrinology, and Diabetes, University of Nantes, Nantes, France","3Department of Internal Medicine, Endocrinology, and Diabetes, University of Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Endocrinology, and Diabetes, University of Nantes, Nantes, France","institution_ids":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"raw_affiliation_string":"3Department of Internal Medicine, Endocrinology, and Diabetes, University of Nantes, Nantes, France","institution_ids":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057323309","display_name":"Geremia B. Bolli","orcid":"https://orcid.org/0000-0003-4966-4003","observed_orcids":["https://orcid.org/0000-0003-4966-4003"]},"institutions":[{"id":"https://openalex.org/I27483092","display_name":"University of Perugia","ror":"https://ror.org/00x27da85","country_code":"IT","type":"education","lineage":["https://openalex.org/I27483092"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Geremia B. Bolli","raw_affiliation_strings":["Department of Internal Medicine, University of Perugia, Perugia, Italy","4Department of Internal Medicine, University of Perugia, Perugia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of Perugia, Perugia, Italy","institution_ids":["https://openalex.org/I27483092"]},{"raw_affiliation_string":"4Department of Internal Medicine, University of Perugia, Perugia, Italy","institution_ids":["https://openalex.org/I27483092"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063044383","display_name":"Mark N. Boldrin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Boldrin","raw_affiliation_strings":["Roche, Nutley, New Jersey","5Roche, Nutley, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, New Jersey","institution_ids":[]},{"raw_affiliation_string":"5Roche, Nutley, New Jersey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081205041","display_name":"Robert E. Ratner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405281094","display_name":"MedStar Health Research Institute","ror":"https://ror.org/03vny0n12","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405281094","https://openalex.org/I86755215"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Ratner","raw_affiliation_strings":["MedStar Health Research Institute, Hyattsville, Maryland","6MedStar Health Research Institute, Hyattsville, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedStar Health Research Institute, Hyattsville, Maryland","institution_ids":["https://openalex.org/I4405281094"]},{"raw_affiliation_string":"6MedStar Health Research Institute, Hyattsville, Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027294690","display_name":"R. Balena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raffaella Balena","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the T-emerge 2 Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"for the T-emerge 2 Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5045489578"],"corresponding_institution_ids":["https://openalex.org/I2800474951"],"apc_list":null,"apc_paid":null,"fwci":8.7657,"has_fulltext":true,"cited_by_count":125,"citation_normalized_percentile":{"value":0.98517267,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"36","issue":"3","first_page":"498","last_page":"504"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.906000018119812},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9900000095367432},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8550000190734863},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9800000190734863},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.796999990940094},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8479999899864197},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.6549999713897705},{"id":"https://openalex.org/keywords/vomiting","display_name":"vomiting","score":0.7179999947547913},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7839999794960022},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.5619999766349792},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9829999804496765},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5040000081062317},{"id":"https://openalex.org/keywords/long-acting-insulin-analogues","display_name":"long-acting insulin analogues","score":0.5879999995231628},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.3959999978542328},{"id":"https://openalex.org/keywords/overweight-adults","display_name":"overweight adults","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9925020933151245},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9064202308654785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7262195348739624},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.674688994884491},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5814372301101685},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.554214596748352},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5138497948646545},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46586182713508606},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4642900228500366},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.44659700989723206},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.41421952843666077},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3411678075790405},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11297446489334106}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2337/dc12-0709","doi":"https://doi.org/10.2337/dc12-0709","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-0709","pdf_url":"https://care.diabetesjournals.org/content/diacare/36/3/498.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2919207","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3579343","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3579343","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3579343/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmid:23139373","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23139373","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.887.6285","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.887.6285","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/early/2012/11/05/dc12-0709.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.905.5040","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.905.5040","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://europepmc.org/backend/ptpmcrender.fcgi?accid%3DPMC3579343%26blobtype%3Dpdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/dc12-0709","doi":"https://doi.org/10.2337/dc12-0709","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-0709","pdf_url":"https://care.diabetesjournals.org/content/diacare/36/3/498.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2094250264.pdf","grobid_xml":"https://content.openalex.org/works/W2094250264.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1976503602","https://openalex.org/W1981183973","https://openalex.org/W1994636940","https://openalex.org/W2007910256","https://openalex.org/W2025995365","https://openalex.org/W2057913111","https://openalex.org/W2138077952","https://openalex.org/W2146901298","https://openalex.org/W2152835319","https://openalex.org/W2152969995","https://openalex.org/W2154292631","https://openalex.org/W2155617439"],"related_works":["https://openalex.org/W1994636940","https://openalex.org/W1868006615","https://openalex.org/W2023859994","https://openalex.org/W1979259269","https://openalex.org/W2120973018","https://openalex.org/W1997761088","https://openalex.org/W2487778189","https://openalex.org/W2043900831"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Taspoglutide":[1,148],"is":[2],"a":[3,44],"long-acting":[4],"glucagon-like":[5],"peptide":[6],"1":[7],"receptor":[8],"agonist":[9],"developed":[10,198],"for":[11],"treatment":[12],"of":[13,21,97,235,255],"type":[14,38],"2":[15,39],"diabetes.":[16],"The":[17,78],"efficacy":[18],"and":[19,179,193,205,207,212,216,259],"safety":[20],"once-weekly":[22],"taspoglutide":[23,50,57,98,121,138,157,172,191,239],"was":[24,82,93,168],"compared":[25],"with":[26,35,171,190,222,227,247,252],"twice-daily":[27,245],"exenatide.":[28,147],"RESEARCH":[29],"DESIGN":[30],"AND":[31],"METHODS:":[32],"Overweight":[33],"adults":[34],"inadequately":[36],"controlled":[37],"diabetes":[40],"on":[41],"metformin":[42],"\u00b1":[43],"thiazolidinedione":[45],"were":[46,182,219,225,231],"randomized":[47],"to":[48,116,129],"subcutaneous":[49],"10":[51,66,106,153,173,192],"mg":[52,59,174,195],"weekly":[53,60],"(n":[54,61,70],"=":[55,62,71],"399),":[56],"20":[58,122,158,194],"398),":[63],"or":[64],"exenatide":[65,104,164,197,246],"\u00b5g":[67],"twice":[68],"daily":[69],"392)":[72],"in":[73,84,202,209,233],"an":[74],"open-label,":[75],"multicenter":[76],"trial.":[77],"primary":[79],"end":[80],"point":[81],"change":[83],"HbA(1c)":[85,92,100,178],"after":[86,184],"24":[87],"weeks.":[88,186],"RESULTS:":[89],"Mean":[90],"baseline":[91],"8.1%.":[94],"Both":[95,137],"doses":[96,139],"reduced":[99,140,149],"significantly":[101,144],"more":[102,145,220],"than":[103,146,170,196,244],"(taspoglutide":[105,152],"mg:":[107,123],"-1.24%":[108],"[SE":[109],"0.09],":[110],"difference":[111,126],"-0.26,":[112],"95%":[113],"CI":[114],"-0.37":[115],"-0.15,":[117],"P":[118,131],"<":[119,132,176],"0.0001;":[120,133],"-1.31%":[124],"[0.08],":[125],"-0.33,":[127],"-0.44":[128],"-0.22,":[130],"exenatide:":[134],"-0.98%":[135],"[0.08]).":[136],"fasting":[141],"plasma":[142],"glucose":[143],"body":[150],"weight":[151,180,249],"mg,":[154,159],"-1.6":[155],"kg;":[156],"-2.3":[160],"kg)":[161],"as":[162],"did":[163],"(-2.3":[165],"kg),":[166],"which":[167],"greater":[169,226,241],"(P":[175],"0.05).":[177],"effects":[181],"maintained":[183],"52":[185],"More":[187],"adverse":[188],"events":[189],"over":[199],"time":[200],"(nausea":[201],"53,":[203],"59,":[204],"35%":[206],"vomiting":[208],"33,":[210],"37,":[211],"16%,":[213],"respectively).":[214],"Allergic":[215],"injection-site":[217,257],"reactions":[218],"common":[221],"taspoglutide.":[223,228],"Discontinuations":[224],"Antitaspoglutide":[229],"antibodies":[230],"detected":[232],"49%":[234],"patients.":[236],"CONCLUSIONS:":[237],"Once-weekly":[238],"demonstrated":[240],"glycemic":[242],"control":[243],"comparable":[248],"loss,":[250],"but":[251],"unacceptable":[253],"levels":[254],"nausea/vomiting,":[256],"reactions,":[258],"systemic":[260],"allergic":[261],"reactions.":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2094250264","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
